facebook pixel

This course is approved for 20.5 credits of continuing medical education (CME) by SynAptiv.

CREDIT STATEMENT 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and LearnHealth Inc. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION

SynAptiv designates this live activity for a maximum of 20.5 AMA PRA Category 1 CreditsPhysicians should claim the credit commensurate with the extent of their participation in the activity.

FOR NURSES

SynAptiv is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031 for 21 contact hours. Nurses should claim the credit commensurate with the extent of their participation in the activity. 

FOR NATUROPATHIC DOCTORS 

The Integrative Dermatology Symposium is approved for 20.5 credits by the American Association of Naturopathic Physicians of which approximately 4.8 are RX (pharmacology CE).

FOR ACUPUNCTURISTS AND ORIENTAL MEDICINE PRACTITIONERS – Application Under Review

The Integrative Dermatology Symposium has applied for accreditation by the National Certification Commission for Acupuncture and Oriental Medicine for 20.5 hours of NCCAOM® PDA Points as Provider #9093.

FOR AYURVEDA PRACTITIONERS 

The Integrative Dermatology Symposium has been approved for 2 TIA and 9 TIW PACE Credits by the National Ayurvedic Medical Association (NAMA). A certificate of completion for this course will be given to all that participate in the 2019 Integrative Dermatology Symposium after completing an evaluation form that will be emailed to you. The PACE listing can be found here.

GOAL & PURPOSE

The annual Integrative Dermatology Symposium is designed to appeal to practitioners across disciplines and will address emerging trends as well as practical approaches to dermatology as practitioners assess and manage skin conditions and care. It is estimated that nearly one-third of the population is afflicted with a skin disorder. There is great need for best practice sharing and cross-collaboration to support practitioners in the field and improve patient outcomes.

TARGET AUDIENCE

This live symposium is designed to meet the educational needs of:

  • Physicians
    • Dermatologists
    • Family Practice Physicians
    • Pediatricians
    • Internists
  • Osteopathic Doctors
  • Naturopathic Doctors
  • Chiropractors
  • Acupuncturists
  • Ayurveda Practitioners
  • Physician Assistants
  • Advanced Practice and Registered Nurses
  • Licensed Herbalists
  • Estheticians

DISCLOSURE OF CONFLICTS OF INTEREST

SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by SynAptiv to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SynAptiv is committed to providing its learners with high-quality activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.

DISCLAIMER

The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of SynAptiv and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.